News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,058 Results
Type
Article (41067)
Company Profile (255)
Press Release (652736)
Section
Business (207853)
Career Advice (2071)
Deals (35831)
Drug Delivery (84)
Drug Development (81775)
Employer Resources (171)
FDA (16216)
Job Trends (15008)
News (350210)
Policy (33003)
Tag
Academia (2617)
Africa (757)
Alliances (49942)
Alzheimer's disease (1166)
Approvals (16144)
Arizona (178)
Artificial intelligence (75)
Asia (38341)
Australia (6294)
Bankruptcy (352)
Best Places to Work (11448)
Biosimilars (65)
Biotechnology (180)
C2C Services and Suppliers (80482)
California (1987)
Canada (967)
Cancer (543)
Career advice (1730)
Cell therapy (134)
China (161)
Clinical research (64142)
Collaboration (161)
Colorado (81)
Compensation (87)
Connecticut (80)
COVID-19 (2523)
Cystic fibrosis (74)
Data (392)
Diabetes (92)
Diagnostics (6109)
Drug pricing (73)
Earnings (85416)
Employer resources (145)
Europe (83133)
Events (110551)
Executive appointments (166)
FDA (16481)
Florida (283)
Funding (167)
Gene therapy (101)
GLP-1 (527)
Government (4390)
Healthcare (18927)
Hotbed/Location (487196)
Illinois (267)
Indiana (152)
Infectious disease (2557)
Inflammatory bowel disease (94)
Interviews (317)
IPO (16401)
Job creations (3710)
Job search strategy (1488)
Kansas (95)
Layoffs (404)
Legal (7961)
Lung cancer (124)
Manufacturing (99)
Maryland (423)
Massachusetts (1606)
Medical device (13299)
Medtech (13304)
Mergers & acquisitions (19318)
Metabolic disorders (270)
Michigan (129)
Minnesota (220)
Neuroscience (1328)
New Jersey (616)
New York (621)
NextGen Class of 2024 (6591)
Non-profit (4566)
North Carolina (625)
Northern California (865)
Obesity (164)
Ohio (110)
Opinion (178)
Patents (77)
Pennsylvania (602)
People (57148)
Phase I (19851)
Phase II (28225)
Phase III (21105)
Pipeline (119)
Postmarket research (2635)
Preclinical (8483)
Press Release (64)
Radiopharmaceuticals (231)
Rare diseases (144)
Real estate (6029)
Recruiting (64)
Regulatory (21633)
Research institute (2369)
Resumes & cover letters (356)
South America (1133)
Southern California (805)
Startups (3616)
Texas (254)
United States (8996)
Vaccines (490)
Washington State (256)
Weight loss (139)
Date
Today (91)
Last 7 days (496)
Last 30 days (2547)
Last 365 days (37200)
2024 (26929)
2023 (40486)
2022 (51674)
2021 (56304)
2020 (54770)
2019 (47460)
2018 (35741)
2017 (32835)
2016 (32300)
2015 (38442)
2014 (32127)
2013 (27106)
2012 (29398)
2011 (30031)
2010 (28126)
694,058 Results for "corium international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
Azitra, Inc. today announced that management will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, California.
May 31, 2024
·
4 min read
BioMidwest
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
Bexion Pharmaceuticals, Inc. announced that the Company will present at the 2024 Biotechnology Innovation Organization International Convention taking place June 3-6, 2024, in San Diego, California.
May 31, 2024
·
2 min read
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Genetown
Corium Announces Publication of Favorable ADLARITY® (donepezil transdermal system) Skin Irritation Clinical Trial Data
Corium, LLC announced today the publication of data reinforcing that ADLARITY (donepezil transdermal system) demonstrated favorable skin tolerability and adhesion in a placebo-controlled trial with healthy volunteers.
September 12, 2023
·
9 min read
Business
International Isotopes Inc. Announces Fiscal Results for Fiscal Year 2023
International Isotopes Inc. announces its financial results for the twelve-month periods ended December 31, 2023.
April 1, 2024
·
6 min read
Genetown
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer’s Disease Treatment ADLARITY® in Multiple Markets Across Asia
Corium, LLC and Lotus Pharmaceutical announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY®, an innovative Alzheimer’s dementia treatment, in ten markets across Asia.
August 10, 2023
·
8 min read
Impact Fusion International Inc. Announces the Commencement of a Research Project with Southern University Agricultural and Research Center (SUARC)
Impact Fusion International Inc. (OTC Pink: IFUS) The Company is pleased to announce that a research project with the Southern University Agricultural and Research Center (SUARC) has begun.
May 13, 2024
·
4 min read
Business
Corium Pharma Solutions Names Two Industry Veterans to its Executive Team
Corium Pharma Solutions, Inc. has named Kevin Ostrander as Chief Business Officer and Dr. Niraj Vasisht as Chief Technology Officer.
February 9, 2023
·
5 min read
Business
Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer
Corium Pharma Solutions, Inc. today announced the appointment of Dr. Mark Sirgo as Chief Executive Officer and member of the Board of Directors.
January 17, 2023
·
5 min read
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
Intellipharmaceutics International Inc. announces its listing on NEX, a separate board of the TSX Venture Exchange.
March 13, 2024
·
5 min read
1 of 69,406
Next
